Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C

Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Emanuele Miraglia del Giudice(University of Campania "Luigi Vanvitelli"), Hamid Hasson(Vita-Salute San Raffaele University), Evangelista Sagnelli(University of Campania "Luigi Vanvitelli"), Grazia Cirillo(University of Campania "Luigi Vanvitelli"), Stefania Salpietro(IRCCS Ospedale San Raffaele), Anna Grandone(University of Campania "Luigi Vanvitelli"), Marco Merli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Carmine Minichini(University of Campania "Luigi Vanvitelli"), Adriano Lazzarin(Vita-Salute San Raffaele University)
Clinical Microbiology and Infection
January 20, 2016
10.1016/j.cmi.2015.11.025
Cited by 15

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168